Khaled Musallam/LinkedIn
May 9, 2026, 13:50
Khaled Musallam: Listening to Patients’ Needs and Challenges Remains the Foundation for a Better Care
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
”One of the most rewarding moments on International Thalassemia Day is sitting together with our patients, hearing firsthand how advances in care and the growth of our center have transformed their disease journey, daily lives, and outlook for the future.
At the same time, these conversations remind us that our work is far from over, and that listening to patients’ persisting needs and challenges remains the foundation for building better and more equitable care.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke